Company intelligence / Profile preview

View Point Medical

Carlsbad, California, United Statesviewpointmed.com ↗

Ownership: Private
Development stage: Preclinical

Overview

View Point Medical has developed and commercialized minimally invasive localization technologies to improve surgical outcomes in oncology. Its core product, the SignalMark platform, includes implantable tissue markers such as the SignalMark Lung Marker and OneMark Breast Localization Marker. These are used with detection imaging systems to enable precise intraoperative localization of cancer lesions. The company’s first product received FDA clearance in 2018, and its latest system was cleared in 2024 for breast lesion marking and detection using ultrasound-based imaging.

Therapeutic areas: Oncology
Modalities: DeviceBioresorbable marker (implantable medical device)
Industry: Implantable Medical Devices

Partnerships

SightLine PartnersEIC Accelerator

Beyond the preview

Go deeper on View Point Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on View Point Medical.

Explore the full profile